| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/27/2001 | EP1109833A2 Compositions and methods for the treatment of tumors |
| 06/27/2001 | EP1109829A1 Human latent transforming growth factor beta binding protein 3 |
| 06/27/2001 | EP1109820A1 Nocathiacin antibiotic derivatives prepared by microbial biotransformation |
| 06/27/2001 | EP1109818A1 Phosphoepoxides, method for making same and uses |
| 06/27/2001 | EP1109817A1 Phosphohalohydrins, method for making same and uses |
| 06/27/2001 | EP1109815A1 Chemokine receptor antagonists and methods of use therefor |
| 06/27/2001 | EP1109814A1 5-heterocyclyl pyrazolo 4,3-d]pyrimidin-7-ones for the treatment of male erectile dysfunction |
| 06/27/2001 | EP1109813A1 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists |
| 06/27/2001 | EP1109812A2 Pyrrolobenzodiazepines |
| 06/27/2001 | EP1109811A2 Pyrrolobenzodiazepines |
| 06/27/2001 | EP1109810A1 Benzonaphthyridine-n-oxides comprising a pde3 and pde4 inhibiting activity |
| 06/27/2001 | EP1109809A1 Pyrroloquinolines for treatment of obesity |
| 06/27/2001 | EP1109808A1 Substituted indole compounds and their use for the treatment of cancer |
| 06/27/2001 | EP1109806A1 Complexes of paroxetine, with cyclodextrins or cyclodextrin derivates |
| 06/27/2001 | EP1109805A1 Inhibitors of bacterial nad synthetase |
| 06/27/2001 | EP1109804A1 Chemokine receptor antagonists and methods of use therefor |
| 06/27/2001 | EP1109803A1 Substituted imidazoles having cytokine inhibitory activity |
| 06/27/2001 | EP1109801A1 Substituted dihydrobenzopyrans useful as antiarrhythmic agents |
| 06/27/2001 | EP1109800A1 Novel cdk inhibitors having flavone structure |
| 06/27/2001 | EP1109799A1 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors |
| 06/27/2001 | EP1109796A1 Telomerase inhibitors and methods of their use |
| 06/27/2001 | EP1109795A1 Thiazoline acid derivatives |
| 06/27/2001 | EP1109794A1 Aza-cyclodepsipeptides and their use as antiparasitics |
| 06/27/2001 | EP1109790A1 1, 2, 4-triazole-3-thione compounds |
| 06/27/2001 | EP1109789A1 Triptolide prodrugs having high aqueous solubility |
| 06/27/2001 | EP1109787A1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 06/27/2001 | EP1109786A1 Piperidine derivatives |
| 06/27/2001 | EP1109785A2 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 06/27/2001 | EP1109784A1 Indoline derivatives as 5-ht2b and/or 5-ht2c receptor ligands |
| 06/27/2001 | EP1109783A2 Gaba uptake inhibitors having a pyrrolidine structure |
| 06/27/2001 | EP1109777A1 N-hydroxyacylamino compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/27/2001 | EP1109580A1 Methods for treating or preventing viral infections and associated diseases |
| 06/27/2001 | EP1109569A2 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 06/27/2001 | EP1109565A1 Gabab1aa receptor |
| 06/27/2001 | EP1109562A1 Composite biocidal particles |
| 06/27/2001 | EP1109561A1 Promoters of neural regeneration |
| 06/27/2001 | EP1109559A2 Inhibition of pathogenic processes related to tissue trauma |
| 06/27/2001 | EP1109558A2 Sustained release ranolazine formulations |
| 06/27/2001 | EP1109557A2 A method for preventing the onset of asthma |
| 06/27/2001 | EP1109556A2 New pharmaceutical uses for nos inhibitors |
| 06/27/2001 | EP1109555A1 Novel angiogenesis inhibitors |
| 06/27/2001 | EP1109554A2 Pipecolic acid derivatives for vision and memory disorders |
| 06/27/2001 | EP1109553A1 Treating inflammatory diseases of the head and neck with cyclooxygenase-2 inhibitors |
| 06/27/2001 | EP1109552A1 Novel dna-cleaving antitumor agents |
| 06/27/2001 | EP1109551A1 4-amino-3-mercapto-1,2,4-triazoles |
| 06/27/2001 | EP1109550A2 Novel nitrophenylaziridine compounds and their use as prodrugs |
| 06/27/2001 | EP1109549A1 Analgesic use of podophyllotoxin for treating pain conditions in female genital organs |
| 06/27/2001 | EP1109548A1 Compositions and methods for treating and preventing bone diseases using tocotrienols |
| 06/27/2001 | EP1109547A1 New use of taxoid derivatives |
| 06/27/2001 | EP1109546A1 Ophthalmic compositions for treating ocular hypertension |
| 06/27/2001 | EP1109545A1 Fc RECEPTOR MODULATORS AND USES THEREOF |
| 06/27/2001 | EP1109544A1 Potassium channel inhibitors and method |
| 06/27/2001 | EP1109543A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 06/27/2001 | EP1109542A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use |
| 06/27/2001 | EP1109539A1 Nanogel networks and biological agent composition thereof |
| 06/27/2001 | EP1109538A1 Anti-inflammatory pharmaceutical formulations |
| 06/27/2001 | EP1109537A1 Immediate release tablet |
| 06/27/2001 | EP1109536A1 New solid dose form of nanoparticulate naproxen |
| 06/27/2001 | EP1109534A1 Quick release pharmaceutical compositions of drug substances |
| 06/27/2001 | EP1109533A1 Pulmonary delivery of liposome-encapsulated cannabinoids |
| 06/27/2001 | EP1109532A1 Oral micro-emulsion composition of silybin |
| 06/27/2001 | EP1109527A2 Cosmetic composition |
| 06/27/2001 | EP1109506A1 Improved method for targeted topical treatment of disease |
| 06/27/2001 | EP1109454A2 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof |
| 06/27/2001 | EP1109453A1 Compositions and methods for treatment of mitochondrial diseases |
| 06/27/2001 | EP1061927A4 Composition for reducing serum cholesterol levels |
| 06/27/2001 | EP0950048B1 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease |
| 06/27/2001 | EP0938472B1 15-fluoro prostaglandins as ocular hypotensives |
| 06/27/2001 | EP0906109B1 Aqueous laxative syrup comprising lactulose and lactitol and/or maltitol |
| 06/27/2001 | EP0862564A4 Photoactivatable compounds for the prevention of intimal hyperplasia and other diseases |
| 06/27/2001 | EP0819113B1 Benzamides for neurodegenerative disorder treatment |
| 06/27/2001 | EP0806953B1 Agent for acting upon bone formation disturbances containing potassium citrates, lactates and/or malates |
| 06/27/2001 | EP0801059B1 Indole derivative |
| 06/27/2001 | EP0800394A4 Prevention of adverse behaviour, diarrhoea, skin disorders and infections of the hind gut associated with acidic conditions in humans and animals |
| 06/27/2001 | EP0797564B1 Lignans, a process for their production and pharmaceutical compositions and uses thereof |
| 06/27/2001 | EP0792167B1 Monofunctional and/or polyfunctional polylysine conjugates |
| 06/27/2001 | EP0767669B1 New pharmaceutical preparation for pain management |
| 06/27/2001 | EP0749960B1 Process for the synthesis of cationic surfactants obtained from the condensation of fatty acids with esterified dibasic aminoacids |
| 06/27/2001 | EP0743854B1 Anti-tumour medical preparation on the basis of carboplatin and the method of its production |
| 06/27/2001 | EP0734261B1 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists |
| 06/27/2001 | EP0733046B1 benzoyl guanidines, their production and their use in medicaments |
| 06/27/2001 | EP0730869B1 Biodegradable medicinal polymer assembly with supermolecular structure |
| 06/27/2001 | EP0727979B1 Novel composition |
| 06/27/2001 | EP0718281B1 Cyclohexanediurea derivative and process for producing the same |
| 06/27/2001 | EP0701554B1 Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof |
| 06/27/2001 | EP0676962B1 Enhanced pharmaceutical compositions for skin penetration for piroxicam |
| 06/27/2001 | EP0660707B1 Amantadine and related compounds for use in the treatment of peripheral neuropathy |
| 06/27/2001 | EP0577648B1 Novel protein polycation conjugates |
| 06/27/2001 | EP0572454B1 Process for the preparation of 29-desmethylrapamycin and its use as antifungal or immunosuppressant agent |
| 06/27/2001 | CN2436153Y Stick chip for penicillin anaphylaxis skin test |
| 06/27/2001 | CN1301298A Methods for prevention and treatment of cancer |
| 06/27/2001 | CN1301268A 15-membered lactams ketolides with antibacterial activity |
| 06/27/2001 | CN1301265A Novel substituted arylhydroxamic acids as metalloproteinase inhibitors |
| 06/27/2001 | CN1301264A Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists |
| 06/27/2001 | CN1301261A Production of furanones |
| 06/27/2001 | CN1301260A Fumagillol derivatives and processes for preparing the same |
| 06/27/2001 | CN1301258A Benzofuroxan derivatives and their use in treating angina pectoris |
| 06/27/2001 | CN1301255A Heterocyclically substituted amides, their production and their use |
| 06/27/2001 | CN1301254A Nonnucleoside inhibitors of reverse transcriptase for the treatment of hiv-infection |
| 06/27/2001 | CN1301253A Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists |